Packaged Medicaments in Egypt | The Observatory of Economic Complexity

About

Exports In 2022, Egypt exported $311M in Packaged Medicaments, making it the 56th largest exporter of Packaged Medicaments in the world. At the same year, Packaged Medicaments was the 30th most exported product in Egypt. The main destination of Packaged Medicaments exports from Egypt are: Saudi Arabia ($41.7M), Yemen ($37.9M), Sudan ($36M), Turkey ($24.6M), and Kuwait ($22.8M).

The fastest growing export markets for Packaged Medicaments of Egypt between 2021 and 2022 were Kuwait ($17.2M), Sudan ($10.4M), and Tanzania ($7.93M).

Imports In 2022, Egypt imported $2.27B in Packaged Medicaments, becoming the 34th largest importer of Packaged Medicaments in the world. At the same year, Packaged Medicaments was the 5th most imported product in Egypt. Egypt imports Packaged Medicaments primarily from: Switzerland ($731M), Belgium ($219M), Germany ($202M), France ($194M), and United States ($164M).

The fastest growing import markets in Packaged Medicaments for Egypt between 2021 and 2022 were Switzerland ($87.2M), United States ($34.3M), and Sweden ($26.3M).

COMPANIES In 2023, leading companies such as were at the forefront of shipping Packaged Medicaments from Egypt to the United States.

Feb 2024

View

LinePlot

StackedArea

Flow

Exports

Imports

Y-AXIS SCALE

Linear

Log

Value

For a full breakdown of trade patterns, visit the trend explorer or the product in country profile.

The following visualization shows the latest trends on Packaged Medicaments. Countries are shown based on data availability.

* Using January 2020 exchange rates when trade data is reported in local currency.

Color

Trade Value

Growth

Growth (%)

Year

EXPORTS (2022)$311M

IMPORTS (2022)$2.27B

NET TRADE (2022)-$1.96B

In 2022, Egypt exported $311M in Packaged Medicaments. The main destinations of Egypt exports on Packaged Medicaments were Saudi Arabia ($41.7M), Yemen ($37.9M), Sudan ($36M), Turkey ($24.6M), and Kuwait ($22.8M).

In 2022, Egypt imported $2.27B in Packaged Medicaments, mainly from Switzerland ($731M), Belgium ($219M), Germany ($202M), France ($194M), and United States ($164M).